Sign in
4

Changes in Ownership

TENAX THERAPEUTICS, INC. Filed Acc 0000899243-22-018968

Options or other derivatives

  • Director acquired 38,181,790 shares (grant or award)
  • Director returned 16,989,736 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table II: Derivative

12 lines
Date Transaction Shares Owned after D/I
2022-05-18 Returned to the company : show line 1 in the form Warrant (right to buy) −4,773,269 0 I
2022-05-18 Grant or award : show line 2 in the form Warrant (right to buy) +4,773,269 4,773,269 I
2022-05-18 Returned to the company : show line 3 in the form Series B Common Stock Purchase Warrants −3,175,924 0 I
2022-05-18 Grant or award : show line 4 in the form Series B Common Stock Purchase Warrants +3,175,924 3,175,924 I
2022-05-18 Returned to the company : show line 5 in the form Series C Common Stock Purchase Warrants −4,607,692 0 I
2022-05-18 Grant or award : show line 6 in the form Series C Common Stock Purchase Warrants +4,607,692 4,607,692 I
2022-05-18 Returned to the company : show line 7 in the form Common Stock Purchase Warrants −2,360,313 0 I
2022-05-18 Grant or award : show line 8 in the form Common Stock Purchase Warrants +2,360,313 2,360,313 I
Loading xslF345X03/doc4.xml…